75 related articles for article (PubMed ID: 2751740)
1. Pharmacokinetics of buflomedil after various dosage forms.
Zecca L; Ferrario P; Pirola R; Reina L; Zambotti F; Zonta N; Lepore AM; Scaglione F; Fraschini F
Arzneimittelforschung; 1989 Apr; 39(4):518-9. PubMed ID: 2751740
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of a sustained release formulation of pyridoxal phosphate of buflomedil after single or repeated oral doses in healthy volunteers.
de Bernardi di Valserra M; Germogli R; Feletti F; Covini D; Borgonovo E
Arzneimittelforschung; 1992 May; 42(5):632-6. PubMed ID: 1530676
[TBL] [Abstract][Full Text] [Related]
3. Dialysis clearance of buflomedil in hemodialysed patients.
Rey E; Moynot A; d'Athis P; Pello JY; Maurel A; Frydman MO; Buisson C; Olive G
Arzneimittelforschung; 1996 May; 46(5):492-5. PubMed ID: 8737633
[TBL] [Abstract][Full Text] [Related]
4. The value of population pharmacokinetics and simulation for postmarketing safety evaluation of dosing guidelines for drugs with a narrow therapeutic index: buflomedil as a case study.
Bourguignon L; Ducher M; Matanza D; Bleyzac N; Uhart M; Odouard E; Maire P; Goutelle S
Fundam Clin Pharmacol; 2012 Apr; 26(2):279-85. PubMed ID: 22004557
[TBL] [Abstract][Full Text] [Related]
5. Relative bioavailability in humans for oral tablets and solutions of lormetazepam.
Zecca L; Reina L; Scaglione F; Ferrario P; Pirola R; Ceccarelli G; Ciampini M; Fraschini F
Arzneimittelforschung; 1985; 35(12):1870-2. PubMed ID: 2869762
[TBL] [Abstract][Full Text] [Related]
6. [Pharmacokinetics and relative bioavailability of KC-404 sustained release tablets in healthy volunteers].
Li T; Pang Y; Wang Z; Jia Y; Cheng Q; Sun J
Sichuan Da Xue Xue Bao Yi Xue Ban; 2003 Jul; 34(3):541-3. PubMed ID: 12910715
[TBL] [Abstract][Full Text] [Related]
7. Effects of controlled-release on the pharmacokinetics and absorption characteristics of a compound undergoing intestinal efflux in humans.
Tubic M; Wagner D; Spahn-Langguth H; Weiler C; Wanitschke R; Böcher WO; Langguth P
Eur J Pharm Sci; 2006 Nov; 29(3-4):231-9. PubMed ID: 16713700
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of tiapride and absolute bioavailability of three extravascular forms.
Rey E; d'Athis P; Richard MO; de Lauture D; Olive G
Int J Clin Pharmacol Ther Toxicol; 1982 Feb; 20(2):62-7. PubMed ID: 7061180
[TBL] [Abstract][Full Text] [Related]
9. Bioavailability of two oral suspension and two oral tablet formulations of acyclovir 400 mg: two single-dose, open-label, randomized, two-period crossover comparisons in healthy Mexican adult subjects.
Palma-Aguirre JA; Absalón-Reyes JA; Novoa-Heckel G; de Lago A; Oliva I; Rodríguez Z; González-de la Parra M; Burke-Fraga V; Namur S
Clin Ther; 2007 Jun; 29(6):1146-52. PubMed ID: 17692728
[TBL] [Abstract][Full Text] [Related]
10. Study on the absolute bioavailability of quinine and theophylline from tablets after single dose oral administration as compared to intravenous infusion in healthy male non-smoking volunteers.
Fuder H; Herzog R; Vaupel W; Wetzelsberger N; Lücker PW
Methods Find Exp Clin Pharmacol; 1994 Nov; 16(9):651-60. PubMed ID: 7746027
[TBL] [Abstract][Full Text] [Related]
11. Zidometacin: pharmacokinetic study on oral absorption.
Bonardi G; Colombo F; Guenzati G; Lepore AM; Sega R
Int J Clin Pharmacol Res; 1984; 4(6):419-23. PubMed ID: 6533086
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of buflomedil after intravenous and oral administration.
Rey E; Barrier G; d'Athis P; de Lauture D; Richard MO; Lirzin JP; Sureau C; Olive G
Int J Clin Pharmacol Ther Toxicol; 1980 Oct; 18(10):437-41. PubMed ID: 7203720
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of two buflomedil tablet formulations in patients with atherosclerotic disease.
Molinaro M; Regazzi MB; Raffaghello S; Buggia I; Iacona I; Graziani P; Specchia G; Melzi D'eril G
J Clin Pharm Ther; 1994 Apr; 19(2):111-5. PubMed ID: 8071390
[TBL] [Abstract][Full Text] [Related]
14. Levetiracetam: relative bioavailability and bioequivalence of a 10% oral solution (750 mg) and 750-mg tablets.
Coupez R; Straetemans R; Sehgal G; Stockis A; Lu ZS
J Clin Pharmacol; 2003 Dec; 43(12):1370-6. PubMed ID: 14615473
[TBL] [Abstract][Full Text] [Related]
15. Absorption, distribution, metabolism, and excretion of N,N-diethyl-M-toluamide in the rat.
Schoenig GP; Hartnagel RE; Osimitz TG; Llanso S
Drug Metab Dispos; 1996 Feb; 24(2):156-63. PubMed ID: 8742226
[TBL] [Abstract][Full Text] [Related]
16. Clinical pharmacokinetics of ibopamine on different diseases and conditions.
Ventresca GP; Lodola E
Arzneimittelforschung; 1988 Aug; 38(8):1175-80. PubMed ID: 2904270
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of cinnarizine after single and multiple dosing in healthy volunteers.
Castañeda-Hernández G; Vargas-Alvarado Y; Aguirre F; Flores-Murrieta FJ
Arzneimittelforschung; 1993 May; 43(5):539-42. PubMed ID: 8328998
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of adimolol after single and multiple dose administration in healthy volunteers.
Wiedemann I; Peil H; Justus H; Adamus S; Brantl V; Lohmann H
Arzneimittelforschung; 1985; 35(6):964-9. PubMed ID: 2862877
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic study of two pharmaceutical preparations containing alkaloid vincamine administered orally to human subjects.
Millart H; Lamiable D; Houin G; Plat M; Choisy H; Tillement JP
Int J Clin Pharmacol Ther Toxicol; 1983 Nov; 21(11):581-6. PubMed ID: 6654533
[TBL] [Abstract][Full Text] [Related]
20. Single-dose bioavailability of levetiracetam intravenous infusion relative to oral tablets and multiple-dose pharmacokinetics and tolerability of levetiracetam intravenous infusion compared with placebo in healthy subjects.
Ramael S; De Smedt F; Toublanc N; Otoul C; Boulanger P; Riethuisen JM; Stockis A
Clin Ther; 2006 May; 28(5):734-44. PubMed ID: 16861095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
